FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
POSSESSION USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
NUCLEAR MEDICINE
PAPER II
NM/D/16/24/II
Time 3 hours
Max. Marks 100
Important instructions:
• Attempt all questions in order.
• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.
• Indicate the question number correctly for the answer in the margin space.
• Answer all the parts of a single question together.
• Start the answer to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. Mention various methods of radio-labelling with 99mTc, positron
emitters and radiopharmaceuticals for therapy.

2. 11C Choline.
99m Tc HYNIC-TOC.
99m Tc DMSA.
18FDOPA.
2.5x4
3. Scintimammography techniques and clinical applications.
Clinical application of 18FLT.
5+5
4. 123 I radiopharmaceuticals and their clinical applications.
QC of 18 FDG.
5+5
5. TNM staging of lung cancer.
Role of PET-CET in the diagnosis and management of Ca lung.
3+7
6. Gleason's score and its applications in Nuclear Medicine
evaluation.
Define CRPC and its importance from Nuclear Medicine point of
view.
5+5
7. Mediastinal nodal stations.
Role of SPECT-CT in sentinel node imaging.
5+5
8. Define SUV. Enumerate various factors influencing the value
and its clinical significance.
Management algorithm of CT contrast related anaphylactic
reactions.

9. Enumerate various Nuclear Medicine techniques in evaluating
the GIT transit.
Role of Nuclear Medicine in the management of esophageal
carcinoma.
3+7
10. Assessment of myocardial viability by nuclear imaging.
Clinical applications of PET/MR in Nuclear Cardiology.
5+5